JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
159 hedge funds and large institutions have $1.27B invested in Juno Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 60 increasing their positions, 43 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
-10
Holders Change %
-5.92%
% of All Funds
3.98%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
26
Increased
60
Reduced
43
Closed
34
Calls
$18.7M
Puts
$27M
Net Calls
-$8.3M
Net Calls Change
-$12.5M
Top Buyers
| 1 |
SCM
Scopia Capital Management
New York
|
$33.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$15.3M |
| 3 |
State Street
Boston,
Massachusetts
|
$64.4M |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
$35.3M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
$6.77M |
